< Go Back

Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37
Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point
Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences
Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights
Pfenex Announces Closing of Initial Public Offering
Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million
Edwards Lifesciences Reports Strong Second Quarter Results
QIAGEN Reports Second Quarter and First Half 2014 Results and Announces Launch of new $100 Million Share Repurchase Program
GSK's Tanzeum™ is now available in pharmacies in the U.S.
Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity
New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015
ISPE Hires Healthcare Association Exec as CEO
Drew Crawford Announces Launch of PBM365 Media
Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo
Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results
EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology
Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform
China Biologic to Report Second Quarter 2014 Financial Results
Cloud Pharmaceuticals Receives Phase I NSF SBIR Grant Valued at $150,000
The BioFusionary Corporation, Inc. Announces Intent To Complete Reverse Takeover Of Australia-Based Continuation Investments Limited
Abide Therapeutics Appoints Nancy Thornberry to Board of Directors
There's Something in the Water: Global Icon, Berocca®, Arrives on U.S. Soil with New Special Formula and Flavor
A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market
Ambit Biosciences To Announce Second Quarter 2014 Financial Results
Phosphagenics Provides Update on Opioid Patch Program
United Therapeutics Corporation Reports Second Quarter 2014 Financial Results
Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer
EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma
Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014
Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update
Diplomat receives distribution contract for Zydelig® (idelalisib)
Alimera Sciences' ILUVIEN® Receives Marketing Authorization In Norway For The Treatment Of Chronic Diabetic Macular Edema
KaloBios Provides Update on KB001-A Partnership and Clinical Status
All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing
Portugal Pharmaceuticals and Healthcare Report Q3 2014
IMBRUVICA® (ibrutinib) Receives Regular Approval by U.S. FDA in Chronic Lymphocytic Leukemia (CLL) and CLL patients with del 17p
U.S. FDA Grants Regular (Full) Approval for IMBRUVICA® for Two Indications
Abbott to Showcase Innovations to Help Labs Solve Health Care Challenges at the American Association for Clinical Chemistry Lab Expo
Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014 On August 12, 2014
Arthur J. Tipton, Ph.D., Named President of Controlled Release Society
BiologicTx® Announces Discovery 2 Life™ Platform (D2L™) and Three-Year Transplant Clinical Outcomes at The World Transplant Congress
Global Rheumatoid Arthritis Drugs Market 2014-2018
LabStyle Innovations Receives Israeli Ministry of Health Approval for the Dario™ Smart Meter
TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card
ALPHAEON Acquires PRN, A Leading Specialty Nutriceutical Company
ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results
Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427
New Chlamydia and Gonorrhea Assays on the BD Viper™ LT System Receive FDA 510k Clearance
Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox® in Primary Liver Cancer
ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development

< Prev Next >
PR Newswire - United Business Media